Literature DB >> 12691634

Familial cardiomyopathies: significant causes of heart failure.

Kathy A Crispell1.   

Abstract

Familial dilated cardiomyopathies (FDCMs) account for about one third of idiopathic dilated cardiomyopathies, yet clinicians under-appreciate their prevalence. Among the inherited cardiomyopathies, FDCMs account for the greatest burden of heart failure and its associated morbidities. This paper summarizes significant molecular-genetic data, and discusses clinical manifestations of the major inherited cardiomyopathies, and the importance of clinical and genetic screening. Suggestions are provided as to how to proceed with screening. The purpose of this paper is to update clinicians about this rapidly growing scientific field, and to encourage application of current evidence to their practices.

Entities:  

Mesh：

Year:  2003        PMID： 12691634     DOI： 10.1007/s11886-003-0047-7

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN： 1523-3782            Impact factor:   2.931


  31 in total

Review 1.  Familial dilated cardiomyopathy: from clinical presentation to molecular genetics.

Authors:  E Arbustini; P Morbini; A Pilotto; A Gavazzi; L Tavazzi
Journal:  Eur Heart J       Date:  2000-11       Impact factor: 29.983

2.  Novel mutation in the alpha-tropomyosin gene and transition from hypertrophic to hypocontractile dilated cardiomyopathy.

Authors:  V Regitz-Zagrosek; J Erdmann; E Wellnhofer; J Raible; E Fleck
Journal:  Circulation       Date:  2000-10-24       Impact factor: 29.690

3.  Clinical features of hypertrophic cardiomyopathy caused by a Lys183 deletion mutation in the cardiac troponin I gene.

Authors:  H Kokado; M Shimizu; H Yoshio; H Ino; K Okeie; Y Emoto; T Matsuyama; M Yamaguchi; T Yasuda; N Fujino; H Ito; H Mabuchi
Journal:  Circulation       Date:  2000-08-08       Impact factor: 29.690

4.  Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice.

Authors:  B K McConnell; K A Jones; D Fatkin; L H Arroyo; R T Lee; O Aristizabal; D H Turnbull; D Georgakopoulos; D Kass; M Bond; H Niimura; F J Schoen; D Conner; D A Fischman; C E Seidman; J G Seidman; D H Fischman
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

Review 5.  Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy.

Authors:  L Mestroni; B Maisch; W J McKenna; K Schwartz; P Charron; C Rocco; F Tesson; A Richter; A Wilke; M Komajda
Journal:  Eur Heart J       Date:  1999-01       Impact factor: 29.983

Review 6.  Prevalence and characteristics of dystrophin defects in adult male patients with dilated cardiomyopathy.

Authors:  E Arbustini; M Diegoli; P Morbini; B Dal Bello; N Banchieri; A Pilotto; F Magani; M Grasso; J Narula; A Gavazzi; M Viganò; L Tavazzi
Journal:  J Am Coll Cardiol       Date:  2000-06       Impact factor: 24.094

7.  Morphologic spectrum of primary restrictive cardiomyopathy.

Authors:  A Angelini; V Calzolari; G Thiene; G M Boffa; M Valente; L Daliento; C Basso; F Calabrese; R Razzolini; U Livi; R Chioin
Journal:  Am J Cardiol       Date:  1997-10-15       Impact factor: 2.778

8.  Clinical profiles of four large pedigrees with familial dilated cardiomyopathy: preliminary recommendations for clinical practice.

Authors:  K A Crispell; A Wray; H Ni; D J Nauman; R E Hershberger
Journal:  J Am Coll Cardiol       Date:  1999-09       Impact factor: 24.094

9.  Linkage of familial dilated cardiomyopathy to chromosome 9. Heart Muscle Disease Study Group.

Authors:  M Krajinovic; B Pinamonti; G Sinagra; M Vatta; G M Severini; J Milasin; A Falaschi; F Camerini; M Giacca; L Mestroni
Journal:  Am J Hum Genet       Date:  1995-10       Impact factor: 11.025

Review 10.  Arrhythmogenic right ventricular dysplasia/cardiomyopathy: need for an international registry. Study Group on Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy of the Working Groups on Myocardial and Pericardial Disease and Arrhythmias of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the World Heart Federation.

Authors:  D Corrado; G Fontaine; F I Marcus; W J McKenna; A Nava; G Thiene; T Wichter
Journal:  Circulation       Date:  2000-03-21       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.